awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35861457-0A8BF284-3079-4875-8880-2AB18B4C1272
Q35861457-0A8BF284-3079-4875-8880-2AB18B4C1272
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35861457-0A8BF284-3079-4875-8880-2AB18B4C1272
Initial testing of lenalidomide by the pediatric preclinical testing program
P2860
Q35861457-0A8BF284-3079-4875-8880-2AB18B4C1272
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35861457-0A8BF284-3079-4875-8880-2AB18B4C1272
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6013820a0605ef820ed94a8268be7b79182a0afc
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.